Together, these results suggest a shared activation of common EMT-related pathways in cancer, bone marrow, and pathological OA contexts, highlighting the role of COL10A1 as a marker of both BMSCs and pro-metastatic tumors. This evidence concerns the gene COL10A1 and cancer.